Deferred Royalty Obligation Related To The Sale Of Future Royalties - Schedule (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred Royalty Obligation [Roll Forward]
Beginning deferred royalty obligation	$ 20,179
Ending deferred royalty obligation	25,527	$ 20,179
Healthcare royalty partners IV, L.P
Deferred Royalty Obligation [Roll Forward]
Beginning deferred royalty obligation	20,179	11,254	$ 0
Upfront payment, net of transaction costs	0	0	9,581
Regulatory approval milestone	0	5,000	0
Non-cash interest expense related to sale of future royalties	7,088	3,924	1,673
Royalty distributed to HCR	(1,740)	0	0
Other	0	1	0
Ending deferred royalty obligation	$ 25,527	$ 20,179	$ 11,254